20 articles for A Thorarensen
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
9
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.

Pfizer
20
3-Arylpiperidines as potentiators of existing antibacterial agents.

Pharmacia
9
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.

Pfizer
10
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists.

Pfizer Inc.
1
Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor.

Pharmacia
1
Preparation of novel anthranilic acids as antibacterial agents: extensive evaluation of structural and physical properties on antibacterial activity and human serum albumin affinity.

Pharmacia
14
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.

Pharmacia
18
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans.

Pfizer
31
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

Karo Pharma
30
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.

Pfizer
2
INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS

Socpra Sciences Sante Et Humaines S.E.C.
16
SUBSTITUTED FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USES THEREOF

Suzhou Yabao Pharmaceutical R&D
22
BIFUNCTIONAL FOLATE RECEPTOR BINDING COMPOUNDS

Lycia Therapeutics
3
SUBSTITUTED TRICYCLIC COMPOUND AS PRMT5 INHIBITOR AND USE THEREOF

NANJING SANHOME PHARMACEUTICAL CO., LTD.
20
Inhibitors of bruton's tyrosine kinase

Hoffmann-La Roche
267
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Boehringer Ingelheim International
34
Overview of the SAMPL5 host-guest challenge: Are we doing better?

University of California San Diego
87
5-substituted indazoles as kinase inhibitors

Abbvie
42
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.

University of Massachusetts Medical School